pentoxifylline has been researched along with Cytokine Release Syndrome in 2 studies
Cytokine Release Syndrome: A severe immune reaction characterized by excessive release of CYTOKINES. Symptoms include DYSPNEA; FEVER; HEADACHE; HYPOTENSION; NAUSEA; RASH; TACHYCARDIA; HYPOXIA; HYPERFERRITINEMIA, and MULTIPLE ORGAN FAILURE. It is associated with viral infections, SEPSIS; AUTOIMMUNE DISEASES and a variety of factors used in IMMUNOTHERAPY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have previously described that pentoxifylline alone, or in combination with oxypurinol, reduces the systemic inflammation caused by experimentally-induced pancreatitis in rats." | 3.96 | Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the ( Franco, L; López-Iranzo, FJ; López-Rodas, AM; López-Rodas, G, 2020) |
| "These changes may lead to hypercytokinemia and the development of cytokine storm with the development of acute lung injury and acute respiratory distress syndrome." | 2.82 | A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19. ( Al-Gareeb, AI; Al-Kuraishy, HM; Batiha, GE; Jeandet, P; Mostafa-Hedeab, G; Saad, HM, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mostafa-Hedeab, G | 1 |
| Al-Kuraishy, HM | 1 |
| Al-Gareeb, AI | 1 |
| Jeandet, P | 1 |
| Saad, HM | 1 |
| Batiha, GE | 1 |
| López-Iranzo, FJ | 1 |
| López-Rodas, AM | 1 |
| Franco, L | 1 |
| López-Rodas, G | 1 |
1 review available for pentoxifylline and Cytokine Release Syndrome
| Article | Year |
|---|---|
A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19.
Topics: Angiotensin-Converting Enzyme 2; Anti-Inflammatory Agents; Antioxidants; COVID-19 Drug Treatment; Cy | 2022 |
1 other study available for pentoxifylline and Cytokine Release Syndrome
| Article | Year |
|---|---|
Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the
Topics: Acute Disease; Animals; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome | 2020 |